tiprankstipranks
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market
AVXL
Anavex Life Sciences
RESEARCH TOOLSreports
Want to see AVXL full AI Analyst Report?

Anavex Life Sciences (AVXL) Financial Statements

1,749 Followers

Anavex Life Sciences Financial Overview

Anavex Life Sciences's market cap is currently $302.11M. The company's EPS TTM is $-0.06; its P/E ratio is -13.95; Anavex Life Sciences is scheduled to report earnings on February 9, 2026, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -51.41M$ -52.88M$ -55.76M$ -50.99M$ -42.00M
EBITDA$ -46.38M$ -43.00M$ -46.54M$ -47.62M$ -37.64M
Net Income$ -46.38M$ -43.00M$ -47.51M$ -47.98M$ -37.91M
Balance Sheet
Cash & Short-Term Investments$ 102.58M$ 132.19M$ 151.02M$ 149.16M$ 152.11M
Total Assets$ 103.81M$ 135.57M$ 154.39M$ 152.70M$ 161.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -102.58M$ -132.19M$ -151.02M$ -149.16M$ -152.11M
Total Liabilities$ 8.95M$ 15.30M$ 12.53M$ 10.21M$ 10.80M
Stockholders' Equity$ 94.87M$ 120.26M$ 141.85M$ 142.49M$ 150.82M
Cash Flow
Free Cash Flow$ -39.04M$ -30.81M$ -27.79M$ -24.24M$ -30.38M
Operating Cash Flow$ -39.04M$ -30.81M$ -27.79M$ -24.24M$ -30.38M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 9.43M$ 11.97M$ 29.65M$ 21.29M$ 153.24M
Currency in USD

Anavex Life Sciences Earnings and Revenue History

Income Statement >

Anavex Life Sciences Debt to Assets

Balance Sheet >

Anavex Life Sciences Cash Flow

Cash Flow >

Anavex Life Sciences Forecast EPS vs Actual EPS

Earnings >